Coronavirus vaccine: AstraZeneca says smaller dosing regime reaches 90% efficacy

Yohay Elam FXStreet

AstraZeneca and the University of Oxford say their COVID-19 vaccine has an average efficacy of 70.4% after recording 131 coronavirus cases within its trial. One dosing regime regiments has shown a higher level of 90% according to the interim results.

The more efficient dosing regime uses half a dose in the first inoculation rather than a full one. That means that more people could be vaccinated using the same amount of material. The 90% efficient regiment is of 1.5 doses rather than two.

From the statement:

One dosing regimen (n=2,741) showed vaccine efficacy of 90% when AZD1222 was given as a half dose, followed by a full dose at least one month apart...

Excitingly, we’ve found that one of our dosing regimens may be around 90% effective and if this dosing regime is used, more people could be vaccinated with planned vaccine supply

AstraZeneca's immunization can be stored at normal cooling temperatures. The firm is set to imminently prepare for emergency regulatory submission. Moderna announced an efficacy of 94.5% and the Pfizer/BioNTech project 95%.

Matt Hancock, the UK's health minister, said that the vaccine is easier to administer and that Britain has 100 million doses in the pipeline. The EU also has a substantial amount of doses for its member states.

Pound/dollar has been standing out in positively responding to immunization news. The currency pair is trading at the highest levels in two months, above 1.33. EUR/USD is also on the rise, changing hands closer to 1.19.

More When the market shivers, the Fed delivers? Where next for markets

Author

Yohay Elam

FXStreet

Yohay is in Forex since 2008 when he founded Forex Crunch, a blog crafted in his free time that turned into a fully-fledged currency website later sold to Finixio.

GBP/USD clings to gains near 1.3400

GBP/USD retreats after reaching a three-week high above 1.3430, challenging the 1.3400 yardstick on Thursday. Although easing political uncertainty in the UK helps the quid limit its downside, escalating tensions in the Middle East support the Greenback, keeping Cable under scrutiny.

EUR/USD: Daily gains appear capped by 1.1450

EUR/USD keeps the recovery in place and looks to consolidate its gains north of 1.1400 the figure at the end of the NA session on Thursday. The pair’s move higher appears in tandem with a modest pullback in the US Dollar despite geopolitical concerns in the Middle East remain unabated.

Gold recovers above $4,100 as traders assess US-Iran conflict

Gold price rebounds to around $4,120 during the early Asian session on Friday. The precious metal edges higher as traders weigh a resumption of war in the Middle East.

BitGo unveils quantum risk management tools for Bitcoin wallets

BitGo has introduced a suite of quantum risk management tools for institutional Bitcoin wallets, aiming to help clients identify, assess and reduce potential exposure to future quantum computing threats before they become a practical concern.

Japan may be changing its Yen strategy, but markets don’t look scared

Japan may be changing its intervention playbook, but that might not be enough to rescue the battered Yen. With USD/JPY hovering at four-decade highs, the currency’s weakness is being driven less by speculative pressure and more by a powerful structural force: the wide US-Japan rate gap.

Bye, forward guidance: How to trade when central banks choose silence

Central banks have spent years telling markets what might come next. Now, traders face the possibility that they say a lot less. From the Federal Reserve to the European Central Bank and the Bank of England, policymakers are pushing back against forward guidance.